Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 263

    1.
    2.

    Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism.

    Chan DC, Watts GF, Ng TW, Uchida Y, Sakai N, Yamashita S, Barrett PH.

    Clin Chem. 2005 Mar;51(3):578-85. Epub 2005 Jan 13.PMID: 15650029 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men.

    Watts GF, Chan DC, Barrett PH, Susekov AV, Hua J, Song S.

    Obes Res. 2003 Jan;11(1):152-9.PMID: 12529498 [PubMed - indexed for MEDLINE]Related articles

    4.

    Adipose tissue compartments and the kinetics of very-low-density lipoprotein apolipoprotein B-100 in non-obese men.

    Watts GF, Chan DC, Barrett PH.

    Metabolism. 2002 Sep;51(9):1206-10.PMID: 12200768 [PubMed - indexed for MEDLINE]Related articles

    6.

    Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.

    Chan DC, Barrett PH, Ooi EM, Ji J, Chan DT, Watts GF.

    J Clin Endocrinol Metab. 2009 Mar;94(3):989-97. Epub 2008 Dec 30.PMID: 19116237 [PubMed - indexed for MEDLINE]Related articles

    7.

    Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.

    Riches FM, Watts GF, Naoumova RP, Kelly JM, Croft KD, Thompson GR.

    Int J Obes Relat Metab Disord. 1998 May;22(5):414-23.PMID: 9622338 [PubMed - indexed for MEDLINE]Related articles

    8.

    Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.

    Riches FM, Watts GF, Hua J, Stewart GR, Naoumova RP, Barrett PH.

    J Clin Endocrinol Metab. 1999 Aug;84(8):2854-61.PMID: 10443691 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.

    Chan DC, Watts GF, Ng TW, Yamashita S, Barrett PH.

    Eur J Clin Invest. 2008 Oct;38(10):743-51.PMID: 18837799 [PubMed - indexed for MEDLINE]Related articles

    10.

    Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.

    Chan DC, Watts GF, Redgrave TG, Mori TA, Barrett PH.

    Metabolism. 2002 Aug;51(8):1041-6.PMID: 12145779 [PubMed - indexed for MEDLINE]Related articles

    11.

    In treatment-naïve and antiretroviral-treated subjects with HIV, reduced plasma adiponectin is associated with a reduced fractional clearance rate of VLDL, IDL and LDL apolipoprotein B-100.

    Das S, Shahmanesh M, Stolinski M, Shojaee-Moradie F, Jefferson W, Jackson NC, Cobbold M, Nightingale P, Umpleby AM.

    Diabetologia. 2006 Mar;49(3):538-42. Epub 2006 Jan 24.PMID: 16432707 [PubMed - indexed for MEDLINE]Related articles

    12.

    Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia.

    Farvid MS, Ng TW, Chan DC, Barrett PH, Watts GF.

    Diabetes Obes Metab. 2005 Jul;7(4):406-13.PMID: 15955127 [PubMed - indexed for MEDLINE]Related articles

    13.

    Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.

    Watts GF, Barrett PH, Ji J, Serone AP, Chan DC, Croft KD, Loehrer F, Johnson AG.

    Diabetes. 2003 Mar;52(3):803-11.PMID: 12606523 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity.

    Watts GF, Riches FM, Humphries SE, Talmud PJ, van Bockxmeer FM.

    J Lipid Res. 2000 Mar;41(3):481-8.PMID: 10706596 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Overproduction of large VLDL particles is driven by increased liver fat content in man.

    Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Häkkinen A, Olofsson SO, Yki-Järvinen H, Borén J.

    Diabetologia. 2006 Apr;49(4):755-65. Epub 2006 Feb 4.PMID: 16463046 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus.

    Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S.

    Metabolism. 2003 Oct;52(10):1274-8.PMID: 14564678 [PubMed - indexed for MEDLINE]Related articles

    17.

    Measurement of liver fat by magnetic resonance imaging: Relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men.

    Chan DC, Watts GF, Ng TW, Hua J, Song S, Barrett PH.

    Diabetes Obes Metab. 2006 Nov;8(6):698-702.PMID: 17026495 [PubMed - indexed for MEDLINE]Related articles

    18.

    Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.

    Chan DC, Watts GF, Nguyen MN, Barrett PH.

    Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):590-6. Epub 2006 Jan 12.PMID: 16410456 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

    Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE.

    Diabetologia. 2003 Apr;46(4):459-69. Epub 2003 Apr 10.PMID: 12687327 [PubMed - indexed for MEDLINE]Related articles

    20.

    Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.

    Chan DC, Watts GF, Barrett PH, O'Neill FH, Thompson GR.

    Obes Res. 2003 Apr;11(4):591-6.PMID: 12690090 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data